Günther G. Steger

The clinical course of lung metastases from breast cancer

G. Steger, M. Baur, C. Dittrich, 1988, Klinische Wochenschrift.

Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia.

C. Gasche, R. Mader, W. Reinisch, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

5-fluorouracil kinetics in the interstitial tumor space: clinical response in breast cancer patients.

T. Helbich, H. Eichler, M. Gnant, 1997, Cancer research.

Prognostic impact of karyotype and immunologic phenotype in 125 adult patients with de novo AML.

C. Marosi, U. Jäger, G. Steger, 1992, Cancer genetics and cytogenetics.

Genetic analysis of multiple synchronous lesions of the colon adenoma–carcinoma sequence

M. Kalipciyan, R. Sedivy, G. Steger, 2000, British Journal of Cancer.

Penetration of capecitabine and its metabolites into malignant and healthy tissues of patients with advanced breast cancer

H. Eichler, B. Rizovski, G. Steger, 2003, British Journal of Cancer.

Brain metastases free survival differs between breast cancer subtypes

M. Gnant, Z. Bago-Horvath, M. Preusser, 2012, British Journal of Cancer.

Resistance to 5-fluorouracil.

R M Mader, G. Steger, R. Mader, 1998, General pharmacology.